Did You Know...
...that Charles Goodyear performed some of his experiments on rubber while in debtor's prison? He was there so often he referred to it as his "hotel". Chronically in debt because of poor business sense and ill health, Goodyear depended on the generosity of friends and family. Even after he unlocked the secret to vulcanizing rubber, he was unable to improve his financial situation. When he died, his estate was $200,000 in debt.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7429408 | Method for preparing calcium aluminate film containing oxygen radical and laminate C12A7 containing oxygen radicals at a high concentration, is provided at a low cost. A method for preparing an oxygen radical-containing calcium aluminate film, characterized in that it comprises subjecting a powder of oxygen radical-containing... | 09/30/2008 |
| 7255882 | Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter functi... | 08/14/2007 |
| 7241459 | Polymers containing bioactive glass with antimicrobial effect The method of protecting a polymeric plastic from attack by bacteria and fungi includes providing bioactive glass particles having a mean particles size preferably less than 2 μm as an additive incorporated into the polymeric plastic. The bioactive glass particles ... | 07/10/2007 |
| 7235225 | 12CaO·7A1O compound and method for preparation thereof There is provided a C12A7 compound capable of selectively and reversibly clathrating X− ions, such as active oxygen radicals, with improved controllability. The C12A7 compound clathrating OH− ions and On− at a concentration of ... | 06/26/2007 |
| 7232579 | Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition A composition contains an inorganic substance obtained as a residue after incinerating skins of marine organisms, and chitin/chitosan. The composition is obtained by incinerating the skins of the marine organisms at a temperature within a range between 600° C. and ... | 06/19/2007 |
| 7226608 | Topical use of microfine calcined alumina Dispersions containing from about 0.5% to about 30% by weight dispersed microfine calcined alumina, stainless steel, or gold particles typically having particle size of less than about 5μ, more narrowly 1μ or less, suspended in a cosmetically acceptable carrier ar... | 06/05/2007 |
| 7223420 | Powder mixture for resorbable calcium phosphate biocements The present invention relates to a powder mixture for resorbable calcium phosphate biocements, which mixture consists of 40–99% by volume of powder having a particle size of 0.1–10 μm, 1–20% by volume of powder having a particle size of 10–43 μm and 0–59... | 05/29/2007 |
| 7198801 | Formulations for transdermal or transmucosal application The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty al... | 04/03/2007 |
| 7179478 | Anemone killing mixture and method for aquariums A method of killing Aiptasia and Majana anemones in aquariums comprises filling a dispenser with an anemone killing mixture, comprising purified water, and effective amounts of calcium hydroxide and non-iodized salt, placing a tip of the filled dispens... | 02/20/2007 |
| 7097859 | Indium supplement compositions and methods therefor A tablet for oral administration of nutritional indium comprises about 10–50 mg indium sulfate, about 4–20 mg caffeine, about 2–10% by weight cocoa powder, and about 5–10% by weight ethyl cellulose, in combination with about 50–150 μg of each of zinc oxid... | 08/29/2006 |
| 7097860 | Method and composition for treatment of inflammatory and inflammation-related disorders A method of reducing inflammation in a variety of disorders by using an intraperitoneal solution of magnesium. The solution can be used for treating inflammatory and inflammation-related disorders in animals and/or humans. Application of the solution reduces inflamm... | 08/29/2006 |
| 7037512 | Topical use of microfine calcined alumina Dispersions containing from about 0.5% to about 30% by weight dispersed microfine calcined alumina, stainless steel, or gold particles typically having particle size of less than about 5μ, more narrowly 1μ or less, suspended in a cosmetically acceptable carrier ar... | 05/02/2006 |
| 7029705 | Nasal hygiene method and composition A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine ... | 04/18/2006 |
| 7029703 | Composition for promoting healthy bone structure A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, f... | 04/18/2006 |
| 6958159 | Pharmaceutical gel composition The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin. ... | 10/25/2005 |
| 6942851 | Composition for the treatment of human hair The invention is directed to an aqueous hair care composition comprising a) at least one UV-absorbing substance, and b) at least one mica/titanium dioxide pigment wherein at least 90% by weight of the mica/titanium dioxide pigment comprises... | 09/13/2005 |
| 6943197 | Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses Provided are methods and topical pharmaceutical formulations for the treatment of inflammatory dermatoses. The invention involves the topical administration of a pharmacologically active base in a formulation having a pH of about 7.5 to about 13.0, preferably about ... | 09/13/2005 |
| 6933420 | Doped odor controlling materials An odor controlling material and an absorbent article containing material for removing or reducing odor emanating from certain gaseous and liquid compounds in body fluid. The odor controlling material includes conventional absorbent materials such as silica, alumina... | 08/23/2005 |
| 6923989 | Method for preparing a calcium phosphate pasty material for injection A method for preparing a calcium phosphate pasty material for injection which after, setting, is designed to form an apatite material consists in: producing from water and calcium phosphates pasty mixture capable of developing, hardening and forming a hydroxyapatite... | 08/02/2005 |
| 6863904 | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoi... | 03/08/2005 |
| 6849274 | Nutritional and pharmaceutical compositions Th present invention relates to nutritional and pharmaceutical compositions. More particularly it is concerned with improving compositions which due to the presence of an efflorescent component may be unstable and prone to decomposition and/or spoilage. The problem ... | 02/01/2005 |
| 6846837 | Topical administration of basic antifungal compositions to treat fungal infections of the nails Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a pharmaceutically acceptable base in a formulation having a pH of 7.5 to about 13... | 01/25/2005 |
| 6841551 | Brain, spinal, and nerve injury treatment A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a ... | 01/11/2005 |
| 6835398 | Method of administering high-dose, oral magnesium for treatment of chronic pain syndrome of erythromelalgia A method of treating patients, particularly for pain and/or symptoms of erythromelalgia, and other neurovascular or neuropathic disorders, etc. involves administering high doses of magnesium. The magnesium is introduced through several daily administrations, totalin... | 12/28/2004 |
| 6827766 | Decontaminating systems containing reactive nanoparticles and biocides Improved area decontamination products and methods of use thereof are provided which include reactive nanoparticles (e.g., metal oxides, hydroxides and mixtures thereof) with one or more biocides and a liquid carrier for the nanoparticles and biocide(s). The product... | 12/07/2004 |
| 6818192 | 12CaO • 7Al2O3 compound clathrating active oxygen species and method for preparing the same The present invention provides a 12CaO.7Al2O3 compound containing an O2− ion radical and/or an O− ion radical in a high concentration of 1020 cm−3 or more. This compound can be used a... | 11/16/2004 |
| 6773814 | Metal oxide particles coated with silicon dioxide Metal oxide particles having a metal oxide core and a silicon dioxide coating have a low structure. The particle are produced by a base dissolved in water being added under agitation to a dispersion comprising a metal oxide, at least one compound of the type Xn... | 08/10/2004 |
| 6767548 | Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture This invention relates to a biocidal composition resistant to the formation of a gel and to the method for stabilizing a concentrate containing, in addition to the biocide, a carbodiimide, a lipophilic/hydrophilic emulsifier mixture having a HLB of 6 to 20 and optio... | 07/27/2004 |
| 6756060 | Anti-inflammatory and antimicrobial uses for bioactive glass compositions Compositions and methods for treating wounds to significantly reduce the healing time, reduce the incidence of scar formation, improve the success of skin grafts, reduce the inflammatory response and providing anti-bacterial treatments to a patient in need thereof, ... | 06/29/2004 |
| 6692775 | Bactericidal gel and method for treating burns and dermal lesions A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a sp... | 02/17/2004 |
| 6692772 | Prevention of in-stent thrombosis and complications after arterial angioplasty with stent placement using magnesium Treatment with magnesium produces a inhibition of acute stent thrombosis under high-shear flow conditions without any hemostatic or significant hemodynamic complications.... | 02/17/2004 |
| 6689392 | Methods and compositions for controlling plant pathogen A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composi... | 02/10/2004 |
| 6685969 | Treatment for ectoparasites Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by ap... | 02/03/2004 |
| 6669928 | Periodontal composition The present invention provides a periodontal composition compounded to include at least one alkaline agent to render a gel or paste having a pH of at least 9.0 to 11.0, and preferably 9.5 to 10.0. The preferred alkaline agent included in the composition i... | 12/30/2003 |
| 6663892 | Multiple portion tablet A solid orally administrable pharmaceutical dosage form for the treatment of gastric disorders includes a first portion containing a therapeutically effective amount of a histamine H2 -receptor antagonist, and a second portion immediately adjac... | 12/16/2003 |
| 6660307 | Process for generating stabilized bromine compounds Active bromine-containing solutions are produced and stabilized by reacting bromate and bromide salt solutions with an amino-complexing agent, such as sulfamic acid or sulfamate salt. The reaction is performed at a pH of less than 1 to create a complexed ... | 12/09/2003 |
| 6653519 | Reactive nanoparticles as destructive adsorbents for biological and chemical contamination Compositions and methods for destroying biological agents such as toxins and bacteria are provided wherein the substance to be destroyed is contacted with finely divided metal oxide or hydroxide nanocrystals. In various embodiments, the metal oxide or met... | 11/25/2003 |
| 6627229 | Antiviral agent and method of producing the same An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the a... | 09/30/2003 |
| 6565891 | Nutritional supplement for children A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.... | 05/20/2003 |
| 6562378 | Nutritional supplement for adolescents A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.... | 05/13/2003 |
